172 related articles for article (PubMed ID: 26406411)
1. Increased levels of serum and tissue miR-107 in human gastric cancer: Correlation with tumor hypoxia.
Ayremlou N; Mozdarani H; Mowla SJ; Delavari A
Cancer Biomark; 2015; 15(6):851-60. PubMed ID: 26406411
[TBL] [Abstract][Full Text] [Related]
2. PRL-3 promotes gastric cancer migration and invasion through a NF-κB-HIF-1α-miR-210 axis.
Zhang C; Tian W; Meng L; Qu L; Shou C
J Mol Med (Berl); 2016 Apr; 94(4):401-15. PubMed ID: 26548949
[TBL] [Abstract][Full Text] [Related]
3. hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer.
Camps C; Buffa FM; Colella S; Moore J; Sotiriou C; Sheldon H; Harris AL; Gleadle JM; Ragoussis J
Clin Cancer Res; 2008 Mar; 14(5):1340-8. PubMed ID: 18316553
[TBL] [Abstract][Full Text] [Related]
4. Circulating microRNA-133, microRNA-17 and microRNA-25 in serum and its potential diagnostic value in gastric cancer.
ZiaSarabi P; Sorayayi S; Hesari A; Ghasemi F
J Cell Biochem; 2019 Aug; 120(8):12376-12381. PubMed ID: 30861177
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-421 regulated by HIF-1α promotes metastasis, inhibits apoptosis, and induces cisplatin resistance by targeting E-cadherin and caspase-3 in gastric cancer.
Ge X; Liu X; Lin F; Li P; Liu K; Geng R; Dai C; Lin Y; Tang W; Wu Z; Chang J; Lu J; Li J
Oncotarget; 2016 Apr; 7(17):24466-82. PubMed ID: 27016414
[TBL] [Abstract][Full Text] [Related]
6. The Value of MiR-383, an Intronic MiRNA, as a Diagnostic and Prognostic Biomarker in Intestinal-Type Gastric Cancer.
Azarbarzin S; Feizi MAH; Safaralizadeh R; Kazemzadeh M; Fateh A
Biochem Genet; 2017 Jun; 55(3):244-252. PubMed ID: 28243881
[TBL] [Abstract][Full Text] [Related]
7. miR-130a acts as a potential diagnostic biomarker and promotes gastric cancer migration, invasion and proliferation by targeting RUNX3.
Jiang H; Yu WW; Wang LL; Peng Y
Oncol Rep; 2015 Sep; 34(3):1153-61. PubMed ID: 26134263
[TBL] [Abstract][Full Text] [Related]
8. HIF-1α Induces Multidrug Resistance in Gastric Cancer Cells by Inducing MiR-27a.
Zhao Q; Li Y; Tan BB; Fan LQ; Yang PG; Tian Y
PLoS One; 2015; 10(8):e0132746. PubMed ID: 26292288
[TBL] [Abstract][Full Text] [Related]
9. The miR-506-Induced Epithelial-Mesenchymal Transition is Involved in Poor Prognosis for Patients with Gastric Cancer.
Sakimura S; Sugimachi K; Kurashige J; Ueda M; Hirata H; Nambara S; Komatsu H; Saito T; Takano Y; Uchi R; Sakimura E; Shinden Y; Iguchi T; Eguchi H; Oba Y; Hoka S; Mimori K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1436-43. PubMed ID: 25707493
[TBL] [Abstract][Full Text] [Related]
10. Identification of serum microRNAs as novel non-invasive biomarkers for early detection of gastric cancer.
Song MY; Pan KF; Su HJ; Zhang L; Ma JL; Li JY; Yuasa Y; Kang D; Kim YS; You WC
PLoS One; 2012; 7(3):e33608. PubMed ID: 22432036
[TBL] [Abstract][Full Text] [Related]
11. Expression level of microRNA-195 in the serum of patients with gastric cancer and its relationship with the clinicopathological staging of the cancer.
Shen YH; Xie ZB; Yue AM; Wei QD; Zhao HF; Yin HD; Mai W; Zhong XG; Huang SR
Eur Rev Med Pharmacol Sci; 2016 Apr; 20(7):1283-7. PubMed ID: 27097947
[TBL] [Abstract][Full Text] [Related]
12. Increased Expression of MicroRNA-221 in gastric cancer and its clinical significance.
Liu K; Li G; Fan C; Diao Y; Wu B; Li J
J Int Med Res; 2012; 40(2):467-74. PubMed ID: 22613407
[TBL] [Abstract][Full Text] [Related]
13. Serum miR-200c expression level as a prognostic biomarker for gastric cancer.
Zhang HP; Sun FB; Li SJ
Genet Mol Res; 2015 Dec; 14(4):15913-20. PubMed ID: 26662382
[TBL] [Abstract][Full Text] [Related]
14. Circulating miR-18a in plasma contributes to cancer detection and monitoring in patients with gastric cancer.
Tsujiura M; Komatsu S; Ichikawa D; Shiozaki A; Konishi H; Takeshita H; Moriumura R; Nagata H; Kawaguchi T; Hirajima S; Arita T; Fujiwara H; Okamoto K; Otsuji E
Gastric Cancer; 2015 Apr; 18(2):271-9. PubMed ID: 24626859
[TBL] [Abstract][Full Text] [Related]
15. Correlation between microRNA-421 expression level and prognosis of gastric cancer.
Liu H; Gao Y; Song D; Liu T; Feng Y
Int J Clin Exp Pathol; 2015; 8(11):15128-32. PubMed ID: 26823855
[TBL] [Abstract][Full Text] [Related]
16. MiR-4728-3p could act as a marker of HER2 status.
Li H; Zhou X; Zhu J; Cheng W; Zhu W; Shu Y; Liu P
Cancer Biomark; 2015; 15(6):807-14. PubMed ID: 26406406
[TBL] [Abstract][Full Text] [Related]
17. Differential distribution of miR-20a and miR-20b may underly metastatic heterogeneity of breast cancers.
Li JY; Zhang Y; Zhang WH; Jia S; Kang Y; Zhu XY
Asian Pac J Cancer Prev; 2012; 13(5):1901-6. PubMed ID: 22901144
[TBL] [Abstract][Full Text] [Related]
18. Plasma miR-940 may serve as a novel biomarker for gastric cancer.
Liu X; Kwong A; Sihoe A; Chu KM
Tumour Biol; 2016 Mar; 37(3):3589-97. PubMed ID: 26456959
[TBL] [Abstract][Full Text] [Related]
19. Combination of miRNA and RNA functions as potential biomarkers for gastric cancer.
Chen S; Zhu J; Yu F; Tian Y; Ma S; Liu X
Tumour Biol; 2015 Dec; 36(12):9909-18. PubMed ID: 26168960
[TBL] [Abstract][Full Text] [Related]
20. Serum microRNA-135a-5p as an auxiliary diagnostic biomarker for colorectal cancer.
Wang Q; Zhang H; Shen X; Ju S
Ann Clin Biochem; 2017 Jan; 54(1):76-85. PubMed ID: 27126269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
